Background
The feasibility and value of transthoracic dobutamine stress echocardiography (DSE) in patients scheduled for bariatric surgery has not been investigated.
Methods
We evaluated 611 patients (86.6% female, 42 ± 10 years, 136 ± 18 kg, BMI 48.0 ± 6.1 kg/m2) referred for DSE prior to surgery between February 2000 and July 2005. Mortality and major cardiovascular events (cardiac death, acute coronary syndrome, and urgent revascularization) were recorded 30-days postoperatively and at 6 months.
Results
Adequate baseline imaging quality was achieved in 590 patients (96.6%), with use of echocardiographic contrast agents in 426 patients (72.2%); the remaining 21 patients (3.4%) were referred for alternative preoperative testing. There were no serious adverse events during DSE, which was negative in 545 patients (92.4%). The test was inconclusive in 38 patients (6.4%), requiring alternative investigations, and positive in 7 patients (1.2%). Eventually, 595 patients proceeded to surgery: 539 with DSE-based risk stratification and 56 with risk stratification based on alternative testing. Laparoscopic procedures were employed in 77.0% of patients. There were 3 perioperative deaths, all attributed to sepsis (perioperative mortality 0.50%), but no major cardiovascular events at 30-days. One patient (evaluated prior to surgery with alternative testing) experienced an acute coronary syndrome during the following 6 months (event rate 0.17%).
Conclusion
Transthoracic DSE is feasible and safe in morbidly obese patients undergoing bariatric surgery; implementation of echocardiographic contrast agents allows for adequate imaging quality in the majority of these patients. However, the very low risk of contemporary bariatric procedures questions the need for routine preoperative stress testing in asymptomatic patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Thom T, Haase N, Rosamond W et al. Heart disease and stroke statistics–2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006; 113: e85–151.
Must A, Spadano J, Coakley EH et al. The disease burden associated with overweight and obesity. JAMA 1999; 282: 1523–9.
Weiss R, Dziura J, Burgert TS et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004; 350: 2362–74.
Fontaine KR, Redden DT, Wang C et al. Years of life lost due to obesity. JAMA 2003; 289: 187–93.
Steinbrook R. Surgery for severe obesity. N Engl J Med 2004; 350: 1075–9.
McTigue KM, Harris R, Hemphill B et al. Screening and interventions for obesity in adults: summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2003; 139: 933–49.
Buchwald H, Avidor Y, Braunwald E et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292: 1724–37.
Dixon JB, Dixon ME, O’Brien PE. Depression in association with severe obesity: changes with weight loss. Arch Intern Med 2003; 163: 2058–65.
Santry HP, Gillen DL, Lauderdale DS. Trends in bariatric surgical procedures. JAMA 2005; 294: 1909–17.
Kertai MD, Boersma E, Bax JJ et al. A meta-analysis comparing the prognostic accuracy of six diagnostic tests for predicting perioperative cardiac risk in patients undergoing major vascular surgery. Heart 2003; 89: 1327–34.
Das MK, Pellikka PA, Mahoney DW et al. Assessment of cardiac risk before nonvascular surgery: dobutamine stress echocardiography in 530 patients. J Am Coll Cardiol 2000;35:1647–53.
Madu EC. Transesophageal dobutamine stress echocardiography in the evaluation of myocardial ischemia in morbidly obese subjects. Chest 2000; 117: 657–61.
Bhat G, Daley K, Dugan M et al. Preoperative evaluation for bariatric surgery using transesophageal dobutamine stress echocardiography. Obes Surg 2004; 14: 948–51.
Picano E, Mathias W Jr, Pingitore A et al. Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, multicentre study. Echo Dobutamine International Cooperative Study Group. Lancet 1994; 344: 1190–2.
Daly AL, Linares OA, Smith MJ et al. Dobutamine pharmacokinetics during dobutamine stress echocardiography. Am J Cardiol 1997; 79: 1381–6.
Cheymol G. Clinical pharmacokinetics of drugs in obesity. An update. Clin Pharmacokinet 1993; 25: 103–14.
Patel KR, White SC, Tejirian T et al. Gallbladder management during laparoscopic Rou-en-Y gastric bypass surgery: routine preoperative screening for gallstones and postoperative prophylactic medical treatment are not necessary. Am Surgeon 2006; 72: 857–61.
Papasavas PK, Gagne DJ, Ceppa FA et al. Routine gallbladder screening not necessary in patients undergoing laparoscopic Rou-en-Y gastric bypass. Surg Obes Relat Dis 2006; 2: 41–7.
Ramaswamy A, Gonzalez R, Smith CD. Extensive preoperative testing is not necessary in morbidly obese patients undergoing gastric bypass. J Gastrointest Surg 2004; 8: 159–64.
Smith SC Jr. Current and future directions of cardiovascular risk prediction. Am J Cardiol 2006; 97: 28A–32A.
Lopez-Jimenez F, Bhatia S, Collazo-Clavell ML et al. Safety and efficacy of bariatric surgery in patients with coronary artery disease. Mayo Clin Proc 2005; 80: 1157–62.
Ponce J, Paynter S, Fromm R. Laparoscopic adjustable gastric banding: 1,014 consecutive cases. J Am Coll Surg 2005; 201: 529–35.
Mokdad AH, Ford ES, Bowman BA et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003; 289: 76–9.
O’Keeffe T, Patterson EJ. Evidence supporting routine polysomnography before bariatric surgery. Obes Surg 2004; 14: 23–6.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lerakis, S., Kalogeropoulos, A.P., El-Chami, M.F. et al. Transthoracic Dobutamine Stress Echocardiography in Patients Undergoing Bariatric Surgery. OBES SURG 17, 1475–1481 (2007). https://doi.org/10.1007/s11695-008-9425-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-008-9425-y